Vigil Neuroscience, Inc. (VIGL) Financials

VIGL Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 159.2 million 23.3 million
2023-06-30 175.4 million 21.6 million
2023-03-31 192.4 million 21.0 million
2022-12-31 200.4 million 11.3 million

VIGL Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -17.4 million 2.4 million
2023-06-30 -15.5 million 2.3 million
2023-03-31 -22.7 million 1.7 million
2022-12-31 -17.4 million 1.5 million

VIGL Net Income

No data available :(

VIGL Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 164.5 million - 14.1 million
2023-06-30 150.2 million - 14.2 million
2023-03-31 164.5 million - 14.7 million
2022-12-31 186.6 million - 176000

VIGL Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 38.8 million
2023-06-30 38.7 million
2023-03-31 38.5 million
2022-12-31 38.5 million

VIGL Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 47000 15.4 million 6.9 million -
2023-06-30 122000 14.9 million 7.0 million -
2023-03-31 492000 13.8 million 6.9 million -
2022-12-31 272000 12.2 million 6.7 million -

VIGL Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 110000
2023-06-30 - 474000
2023-03-31 - 383000
2022-12-31 - 274000

VIGL

Price: $3.03

52 week price:
2.53
11.11

Earnings Per Share: -2.13 USD

P/E Ratio: -1.45

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 7969

Market Capitalization: 122.1 million

Links: